Allan Jonathan
CIK 1966716
Transactions on file
32
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-02 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 627 | $16.5K | -2.4% | open → |
| 2026-08-19 | 2026-08-18 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 145 | $4.7K | -20.8% | open → |
| 2026-08-19 | 2026-08-18 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 2,716 | $86.9K | -19.7% | open → |
| 2026-08-19 | 2026-08-14 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Exer. | 6,000 | $0.00 | — | open → |
| 2026-06-18 | 2026-06-16 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 1,457 | $43.6K | -14.2% | open → |
| 2025-03-18 | 2025-03-15 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Exer. | 7,475 | $0.00 | — | open → |
| 2025-03-18 | 2025-03-15 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Exer. | 6,000 | $0.00 | — | open → |
| 2025-03-20 | 2025-03-18 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Sale | 2,266 | $19.6K | +196.4% | open → |
| 2025-03-20 | 2025-03-19 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Sale | 1,945 | $16.1K | +210.8% | open → |
| 2025-12-10 | 2025-12-08 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 2,678 | $87.3K | -21.2% | open → |
| 2025-12-10 | 2025-12-08 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 1,300 | $41.1K | -18.7% | open → |
| 2025-12-05 | 2025-12-05 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 2,344 | $74.4K | -19.1% | open → |
| 2025-12-05 | 2025-12-05 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 5,437 | $169.0K | -17.3% | open → |
| 2025-12-05 | 2025-12-05 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 1,004 | $31.5K | -18.0% | open → |
| 2025-12-05 | 2025-12-04 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 194 | $6.1K | -17.9% | open → |
| 2025-12-05 | 2025-12-04 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 824 | $25.3K | -16.5% | open → |
| 2025-12-05 | 2025-12-03 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Exer. | 6,000 | $0.00 | — | open → |
| 2025-12-03 | 2025-12-03 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 1,394 | $43.0K | -16.7% | open → |
| 2025-12-03 | 2025-12-03 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 898 | $27.2K | -15.3% | open → |
| 2025-12-03 | 2025-12-02 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 868 | $26.2K | -14.7% | open → |
| 2025-12-03 | 2025-12-02 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 1,416 | $41.9K | -13.1% | open → |
| 2025-12-03 | 2025-12-01 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Exer. | 12,357 | $0.00 | — | open → |
| 2025-10-07 | 2025-10-03 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Sale | 10,000 | $250.7K | +2.5% | open → |
| 2025-10-07 | 2025-10-03 | STOK Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Exer. | 10,000 | $91.5K | +180.9% | open → |
| 2025-08-15 | 2025-08-13 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Sale | 13,712 | $205.7K | +71.3% | open → |
| 2025-08-18 | 2025-08-14 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Exer. | 6,000 | $0.00 | — | open → |
| 2025-08-20 | 2025-08-18 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Sale | 1,683 | $30.7K | +40.9% | open → |
| 2025-09-03 | 2025-09-02 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Exer. | 9,150 | $64.7K | +263.5% | open → |
| 2025-09-03 | 2025-09-02 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Sale | 14,922 | $300.5K | +27.6% | open → |
| 2025-09-03 | 2025-09-03 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Sale | 6,345 | $127.3K | +28.1% | open → |
| 2025-09-03 | 2025-08-29 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Sale | 850 | $17.0K | +28.5% | open → |
| 2025-09-03 | 2025-08-29 | STOK Stoke Therapeutics, Inc. | Officer GENERAL COUNSEL & CORP SEC | Exer. | 850 | $6.0K | +263.5% | open → |
